Plasma CellsMultiple MyelomaBone MarrowBone Marrow TransplantationParaproteinemiasBone Marrow CellsTransplantation, AutologousTransplantation, HomologousPrognosisFlow CytometryHematopoietic Stem Cell TransplantationParaproteinsB-LymphocytesBone and BonesGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationAmyloidosisBone Marrow PurgingHematopoietic Stem CellsGraft SurvivalStem Cell TransplantationKidney TransplantationLeukemiaTransplantation ChimeraAnemia, AplasticBusulfanBone Marrow DiseasesTissue DonorsCyclophosphamideCombined Modality TherapyTreatment OutcomeBone Marrow ExaminationHematopoiesisRecurrenceBone RemodelingHistocompatibility TestingMelphalanLymphoma, Non-HodgkinBone Marrow NeoplasmsTransplantation, IsogeneicRemission InductionTime FactorsMice, Inbred C57BLHistocompatibilityHeart TransplantationHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionAntigens, CD34Leukemia, Myeloid, AcuteHematopoietic Stem Cell MobilizationPeripheral Blood Stem Cell TransplantationColony-Forming Units AssayLung TransplantationGranulocyte Colony-Stimulating FactorLeukemia, Plasma CellAntineoplastic Combined Chemotherapy ProtocolsRadiation ChimeraSurvival AnalysisCarmustineCell DifferentiationTransplantation ImmunologyCell TransplantationBone DensityRetrospective StudiesCells, CulturedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesImmunosuppressionOrgan TransplantationDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesBone ResorptionSurvival RateSalvage TherapyCytarabineEtoposideFollow-Up StudiesLeukemia, MyeloidHodgkin DiseaseAcute DiseaseGraft vs Tumor EffectHepatic Veno-Occlusive DiseaseLymphocyte DepletionLymphomaCell SeparationGraft vs Host ReactionSpleenChimeraHLA AntigensLeukocyte TransfusionBone NeoplasmsCyclosporineSevere Combined ImmunodeficiencyPancreas TransplantationAntibodies, MonoclonalMice, Inbred BALB C